Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas
- 28 November 2015
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 140 (2), 226-233
- https://doi.org/10.1016/j.ygyno.2015.11.032
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 27 references indexed in Scilit:
- Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid typeGynecologic Oncology, 2014
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant TherapyJNCI Journal of the National Cancer Institute, 2011
- Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: Results from studies of the NCIC Clinical Trials Group (NCIC CTG)European Journal of Cancer, 2010
- Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinomaGynecologic Oncology, 2009
- “BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 MutationsJournal of Clinical Oncology, 2008
- Microsatellite Instability and Epigenetic Inactivation of MLH1 and Outcome of Patients With Endometrial Carcinomas of the Endometrioid TypeJournal of Clinical Oncology, 2007
- Clinicopathologic Significance of Defective DNA Mismatch Repair in Endometrial CarcinomaJournal of Clinical Oncology, 2006
- Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon CancerNew England Journal of Medicine, 2003
- Clinical significance of microsatellite instability in endometrial carcinomaCancer, 2000
- Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancerThe Lancet, 2000